Liver-Focused combo could ease diabetes eye swelling

NCT ID NCT07457632

First seen Mar 30, 2026 · Last updated May 15, 2026 · Updated 6 times

Summary

This study tests a new way to treat diabetic macular edema (DME), a serious eye complication of diabetes that causes vision loss. Instead of standard eye injections, researchers will give 69 participants a bile acid supplement and a traditional Chinese medicine formula that target the liver to reduce inflammation and eye swelling. The goal is to see if this non-invasive, multi-targeted approach can improve vision and eye health markers over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA (DME) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35243, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.